药物对比
Linagliptin vs Ertugliflozin
Linagliptin 与 Ertugliflozin：DPP-4与SGLT2抑制剂治疗2型糖尿病。比较疗效、心血管/肾脏获益、副作用及哪种更好。
此页面暂无可用的对比维度。
临床背景
This comparison arises when selecting between DPP-4 and SGLT2 inhibitors for type 2 diabetes, particularly with cardiovascular, renal, or weight management considerations.
结论
Ertugliflozin often edges out for added cardio-renal benefits, but Linagliptin may be preferable in certain renal or infection-risk scenarios.
全部药物对比